CCRB Logo

Trial Detail

CUHK_CCRB00579

2018-01-17

Prospective

N.A.

Direct Grant CUHK

Hon KL, sponsored by Direct Grant CUHK

N.A.

Not Applicable

Esther Lam

Department of Paediatrics, 6/F Prince of Wales Hospital, Shatin

35052982

esther-lam@cuhk.edu.hk

Hospital Authority

Hong Kong, China

Kam Lun HON

Department of Paediatrics, 6/F Prince of Wales Hospital, Shatin

35052856

ehon@cuhk.edu.hk

The Chinese University of Hong Kong

Hong Kong, China

Effect of pine-tar shower on itch and diseae severity in moderate-to-severe childhood eczema

Effect of pine-tar shower on childhood eczema

松焦油沐浴對濕疹病童接受水平及金黃葡萄球菌的治療情況

Omit

Hong Kong, China

Yes

2017-08-24

Joint CUHK-NTEC Clinical Research Ethics Committee

2017.399-T

Eczema

Other

Pine tar bath oil

Product name: Pinetarsol
(pine tar bath oil 2.3% w/w)

N.A.

10-20ml daily

4 weeks (active arm)

10-15 min. daily

Placebo: QV Baby Bath Oil

N.A.

10-20ml daily

4 weeks

10-15 min. daily

- only patients with moderate-to-severe eczema of SCORAD (SCORing Atopic Dermatitis) scores >15 points will be recruited

- Subjects (patients and parents) have intercurrent illness for two weeks prior to study

- received any systemic antibiotics for at least 4 weeks prior

- subject with documented allergies to study product components

- subject enrolled in another clinical trial during the study period

- subject/parent considered by teh investigator to be likely not compliant to be likely not compliant to the protocol

3

18

Both Male and Female

Interventional

Randomized

through computerized randomization generated by a research staff not involved in the trial.

Placebo

Single-blind

Investigator/research team

Crossover

Other

N.A.

2018-01-31

40

Not Yet Recruiting

eczema severity

by SCORAD (SCORing Atopic Dermatitis); modified POEM (Patient Oriented Eczema Measure)

S. aureus status (absent, scantly, moderate, heavy growth) during the study period

by skin swab

Skin hydration (SH) and transepidermal water loss (TEWL)

by MoistureMeterSC and Vapometer (Delfin Technologies Ltd, Kuopio, Finland)

Quality of life

by CDLQI (Children's Dermatology Life Quality Index)

Eczema severity blood markers (eg. ige, eosinophils)

No

2018-01-25

ChiCTR1800014627

2018-01-17

Type Document Published On  
No documents yet.
  • Page 1 of 1.